PAA 2.50% 20.5¢ pharmaust limited

PAA Post AGM ,, 2022 Highlights, page-105

  1. 737 Posts.
    lightbulb Created with Sketch. 1479
    WHO IS KEN???
    Honestly, some of you guys are whipping your collective selves into a frenzy.

    Jock, so much of what you're saying (e.g.: retrospective data gathering) was announced to the market months and months ago! Whenever you read something about extension of survivial - guess what?

    It's retrospective! NOT part of the trial and never was.
    It was discovered by a fortunate accident through retrospective analysis of the trial data. Aren't we lucky!!

    As it turns out it's the most promising commercial development news we've had, and you're treating it like some kind of "Gotcha!" moment.

    They're not "now saying" it, it's been known for ages! Look over goodness knows how many updates and see - whenever they talk about MPL + Prednisolone, it's retrospective analysis. And while it doesn't contribute to the close out of the current Phase 2, it sure as hell will shape the Phase 3.

    All this trawling over the AGM video looking for something bad is doing my head in!

    If some of our HC posters were on the Titanic they'd be looking for the nearest anvil to grab hold of.

    Wow....Just wow.

 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.